Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus
Abstract
:1. Introduction
2. Materials and Methods
2.1. Cells
2.2. Plasmids
2.3. Viruses
2.4. Growth Kinetics and Virus Titration
2.5. Minigenome and trVLP Assays
2.6. Statistical Analysis
3. Results
3.1. RESTV Growth Is Impaired Compared to EBOV in Both IFN-Deficient and Competent Cells
3.2. EBOV and RESTV GP and VP40 Have Identical Entry and Budding Efficiency
3.3. EBOV and RESTV RNP Proteins Show Different Efficiencies in Viral RNA Synthesis
3.4. Even under Optimized Conditions, RESTV RNP Proteins Are Less Efficient in Viral RNA Synthesis Than EBOV RNP Proteins
4. Discussion
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Muhlberger, E.; Weik, M.; Volchkov, V.E.; Klenk, H.D.; Becker, S. Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems. J. Virol. 1999, 73, 2333–2342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Banadyga, L.; Hoenen, T.; Ambroggio, X.; Dunham, E.; Groseth, A.; Ebihara, H. Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging. Sci. Rep. 2017, 7, 7698. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reid, S.P.; Leung, L.W.; Hartman, A.L.; Martinez, O.; Shaw, M.L.; Carbonnelle, C.; Volchkov, V.E.; Nichol, S.T.; Basler, C.F. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 2006, 80, 5156–5167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Watt, A.; Moukambi, F.; Banadyga, L.; Groseth, A.; Callison, J.; Herwig, A.; Ebihara, H.; Feldmann, H.; Hoenen, T. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity. J. Virol. 2014, 88, 10511–10524. [Google Scholar] [CrossRef] [Green Version]
- Noda, T.; Sagara, H.; Suzuki, E.; Takada, A.; Kida, H.; Kawaoka, Y. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J. Virol. 2002, 76, 4855–4865. [Google Scholar] [CrossRef] [Green Version]
- Moller-Tank, S.; Maury, W. Ebola virus entry: A curious and complex series of events. PLoS Pathog. 2015, 11, e1004731. [Google Scholar] [CrossRef]
- Bowen, E.T.; Lloyd, G.; Harris, W.J.; Platt, G.S.; Baskerville, A.; Vella, E.E. Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent. Lancet 1977, 1, 571–573. [Google Scholar] [CrossRef]
- WHO. Ebola Virus Disease—Democratic Republic of the Congo—External Situation Report 95. Available online: https://www.who.int/publications/i/item/10665-332254 (accessed on 10 June 2020).
- Baize, S.; Pannetier, D.; Oestereich, L.; Rieger, T.; Koivogui, L.; Magassouba, N.; Soropogui, B.; Sow, M.S.; Keita, S.; De Clerck, H.; et al. Emergence of Zaire Ebola virus disease in Guinea. N. Engl. J. Med. 2014, 371, 1418–1425. [Google Scholar] [CrossRef] [Green Version]
- Penas, J.A.; Miranda, M.E.; de Los Reyes, V.C.; Sucaldito, M.N.L.; Magpantay, R.L. Risk assessment of Ebola Reston virus in humans in the Philippines. West. Pac. Surveill. Response J. 2019, 10, 1–8. [Google Scholar] [CrossRef]
- Geisbert, T.W.; Jahrling, P.B. Use of immunoelectron microscopy to show Ebola virus during the 1989 United States epizootic. J. Clin. Pathol. 1990, 43, 813–816. [Google Scholar] [CrossRef] [Green Version]
- Geisbert, T.W.; Rhoderick, J.B.; Jahrling, P.B. Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy. J. Clin. Pathol. 1991, 44, 521–522. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pan, Y.; Zhang, W.; Cui, L.; Hua, X.; Wang, M.; Zeng, Q. Reston virus in domestic pigs in China. Arch. Virol. 2014, 159, 1129–1132. [Google Scholar] [CrossRef] [PubMed]
- Barrette, R.W.; Metwally, S.A.; Rowland, J.M.; Xu, L.; Zaki, S.R.; Nichol, S.T.; Rollin, P.E.; Towner, J.S.; Shieh, W.J.; Batten, B.; et al. Discovery of swine as a host for the Reston ebolavirus. Science 2009, 325, 204–206. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Raymond, J.; Bradfute, S.; Bray, M. Filovirus infection of STAT-1 knockout mice. J. Infect. Dis. 2011, 204 (Suppl. 3), S986–S990. [Google Scholar] [CrossRef]
- Bray, M. The role of the Type I interferon response in the resistance of mice to filovirus infection. J. Gen. Virol. 2001, 82, 1365–1373. [Google Scholar] [CrossRef]
- Escudero-Perez, B.; Ruibal, P.; Rottstegge, M.; Ludtke, A.; Port, J.R.; Hartmann, K.; Gomez-Medina, S.; Muller-Guhl, J.; Nelson, E.V.; Krasemann, S.; et al. Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice. JCI Insight 2019, 4. [Google Scholar] [CrossRef] [Green Version]
- Fisher-Hoch, S.P.; Brammer, T.L.; Trappier, S.G.; Hutwagner, L.C.; Farrar, B.B.; Ruo, S.L.; Brown, B.G.; Hermann, L.M.; Perez-Oronoz, G.I.; Goldsmith, C.S.; et al. Pathogenic potential of filoviruses: Role of geographic origin of primate host and virus strain. J. Infect. Dis. 1992, 166, 753–763. [Google Scholar] [CrossRef]
- Schwarz, T.M.; Edwards, M.R.; Diederichs, A.; Alinger, J.B.; Leung, D.W.; Amarasinghe, G.K.; Basler, C.F. VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability. J. Virol. 2017, 91. [Google Scholar] [CrossRef] [Green Version]
- Reid, S.P.; Valmas, C.; Martinez, O.; Sanchez, F.M.; Basler, C.F. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J. Virol. 2007, 81, 13469–13477. [Google Scholar] [CrossRef] [Green Version]
- Leung, D.W.; Shabman, R.S.; Farahbakhsh, M.; Prins, K.C.; Borek, D.M.; Wang, T.; Muhlberger, E.; Basler, C.F.; Amarasinghe, G.K. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J. Mol. Biol. 2010, 399, 347–357. [Google Scholar] [CrossRef] [Green Version]
- Groseth, A.; Marzi, A.; Hoenen, T.; Herwig, A.; Gardner, D.; Becker, S.; Ebihara, H.; Feldmann, H. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog. 2012, 8, e1002847. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olejnik, J.; Forero, A.; Deflube, L.R.; Hume, A.J.; Manhart, W.A.; Nishida, A.; Marzi, A.; Katze, M.G.; Ebihara, H.; Rasmussen, A.L.; et al. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages. J. Virol. 2017, 91. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boehmann, Y.; Enterlein, S.; Randolf, A.; Muhlberger, E. A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire. Virology 2005, 332, 406–417. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Spengler, J.R.; Saturday, G.; Lavender, K.J.; Martellaro, C.; Keck, J.G.; Nichol, S.T.; Spiropoulou, C.F.; Feldmann, H.; Prescott, J. Severity of Disease in Humanized Mice Infected with Ebola Virus or Reston Virus Is Associated with Magnitude of Early Viral Replication in Liver. J. Infect. Dis. 2017, 217, 58–63. [Google Scholar] [CrossRef] [Green Version]
- Negredo, A.; Palacios, G.; Vazquez-Moron, S.; Gonzalez, F.; Dopazo, H.; Molero, F.; Juste, J.; Quetglas, J.; Savji, N.; de la Cruz Martinez, M.; et al. Discovery of an ebolavirus-like filovirus in europe. PLoS Pathog. 2011, 7, e1002304. [Google Scholar] [CrossRef] [Green Version]
- Yang, X.L.; Tan, C.W.; Anderson, D.E.; Jiang, R.D.; Li, B.; Zhang, W.; Zhu, Y.; Lim, X.F.; Zhou, P.; Liu, X.L.; et al. Characterization of a filovirus (Mengla virus) from Rousettus bats in China. Nat. Microbiol. 2019, 4, 390–395. [Google Scholar] [CrossRef]
- Goldstein, T.; Anthony, S.J.; Gbakima, A.; Bird, B.H.; Bangura, J.; Tremeau-Bravard, A.; Belaganahalli, M.N.; Wells, H.L.; Dhanota, J.K.; Liang, E.; et al. The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses. Nat. Microbiol. 2018, 3, 1084–1089. [Google Scholar] [CrossRef]
- Wendt, L.; Bostedt, L.; Hoenen, T.; Groseth, A. High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics. Antiviral. Res. 2019, 170, 104569. [Google Scholar] [CrossRef]
- Holzerland, J.; Feneant, L.; Banadyga, L.; Hölper, J.; Knittler, M.R.; Groseth, A. BH3-only sensors Bad, Noxa and Puma are Key Regulators of Tacaribe virus-induced Apoptosis. PLoS Pathog. 2020. in revision. [Google Scholar]
- Groseth, A.; Feldmann, H.; Theriault, S.; Mehmetoglu, G.; Flick, R. RNA polymerase I-driven minigenome system for Ebola viruses. J. Virol. 2005, 79, 4425–4433. [Google Scholar] [CrossRef] [Green Version]
- Shabman, R.S.; Hoenen, T.; Groseth, A.; Jabado, O.; Binning, J.M.; Amarasinghe, G.K.; Feldmann, H.; Basler, C.F. An upstream open reading frame modulates ebola virus polymerase translation and virus replication. PLoS Pathog. 2013, 9, e1003147. [Google Scholar] [CrossRef] [PubMed]
- Wulff, N.H.; Tzatzaris, M.; Young, P.J. Monte Carlo simulation of the Spearman-Kaerber TCID50. J. Clin. Bioinform. 2012, 2, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ryabchikova, E.I.; Kolesnikova, L.V.; Luchko, S.V. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J. Infect. Dis. 1999, 179 (Suppl. 1), S199–S202. [Google Scholar] [CrossRef] [PubMed]
- Watanabe, S.; Watanabe, T.; Noda, T.; Takada, A.; Feldmann, H.; Jasenosky, L.D.; Kawaoka, Y. Production of novel ebola virus-like particles from cDNAs: An alternative to ebola virus generation by reverse genetics. J. Virol. 2004, 78, 999–1005. [Google Scholar] [CrossRef] [Green Version]
- Kamper, L.; Zierke, L.; Schmidt, M.L.; Muller, A.; Wendt, L.; Brandt, J.; Hartmann, E.; Braun, S.; Holzerland, J.; Groseth, A.; et al. Assessment of the function and intergenus-compatibility of Ebola and Lloviu virus proteins. J. Gen. Virol. 2019, 100, 760–772. [Google Scholar] [CrossRef]
- Hoenen, T.; Jung, S.; Herwig, A.; Groseth, A.; Becker, S. Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 2010, 403, 56–66. [Google Scholar] [CrossRef] [Green Version]
- Weik, M.; Enterlein, S.; Schlenz, K.; Muhlberger, E. The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J. Virol. 2005, 79, 10660–10671. [Google Scholar] [CrossRef] [Green Version]
- Bach, S.; Biedenkopf, N.; Grunweller, A.; Becker, S.; Hartmann, R.K. Hexamer phasing governs transcription initiation in the 3′-leader of Ebola virus. RNA 2020, 26, 439–453. [Google Scholar] [CrossRef]
- Watanabe, S.; Noda, T.; Halfmann, P.; Jasenosky, L.; Kawaoka, Y. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J. Infect. Dis. 2007, 196 (Suppl. 2), S284–S290. [Google Scholar] [CrossRef] [Green Version]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bodmer, B.S.; Greßler, J.; Schmidt, M.L.; Holzerland, J.; Brandt, J.; Braun, S.; Groseth, A.; Hoenen, T. Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus. Microorganisms 2020, 8, 1215. https://doi.org/10.3390/microorganisms8081215
Bodmer BS, Greßler J, Schmidt ML, Holzerland J, Brandt J, Braun S, Groseth A, Hoenen T. Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus. Microorganisms. 2020; 8(8):1215. https://doi.org/10.3390/microorganisms8081215
Chicago/Turabian StyleBodmer, Bianca S., Josephin Greßler, Marie L. Schmidt, Julia Holzerland, Janine Brandt, Stefanie Braun, Allison Groseth, and Thomas Hoenen. 2020. "Differences in Viral RNA Synthesis but Not Budding or Entry Contribute to the In Vitro Attenuation of Reston Virus Compared to Ebola Virus" Microorganisms 8, no. 8: 1215. https://doi.org/10.3390/microorganisms8081215